Skip to main content
. 2024 Nov 6;15:1485306. doi: 10.3389/fgene.2024.1485306

TABLE 5.

Service outcomes (definite final diagnosis and sources of referral) among women who proceeded with prenatal ES in each GLH.

GLH 1 (n = 36) GLH 2 (n = 22) GLH 3 (n = 48) GLH 4 (n = 11) GLH 5 n = 63) GLH 6 (n = 28) GLH 7 (n = 33) Total (N = 241) p-value
n (%) n (%) n (%) n (%) n (%) n (%) n (%) n (%)
Definite diagnosis (Diagnostic yield)
 No 21 (58.3) 15 (68.2) 30 (62.5) 6 (54.5) 43 (68.3) 20 (71.4) 21 (63.6) 156 (64.7) 0.89
 Yes 15 (41.7) 7 (31.8) 18 (37.5) 5 (45.5) 20 (31.7) 8 (28.6) 12 (36.4) 85 (35.3)
Sources of Referral
 Genetics 1 (2.9) 11 (50.0) 48 (100.0) 11 (100.0) 26 (52.0) 20 (71.4) 9 (27.3) 126 (55.5) NC
 Fetal medicine/Genetics 25 (71.4) 11 (50.0) 0 (0.0) 0 (0.0) 24 (48.0) 7 (25.0) 24 (72.7) 91 (40.1)
 Fetal medicine 9 (25.7) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 1 (3.6) 0 (0.0) 10 (4.4)
Missing 1 0 0 0 13 0 0 14

Note: Diagnostic yield: Yes: Pathogenic variant reported, No: VUS, or no pathogenic variant reported.

p-value from chi-square test.

Abbreviations: ES: exome sequencing, GLH: genomic laboratory hub, NC: Not computed (because of multiple zeroes for fetal medicine).